JENNA CARROLL: Open Payments
NPI 1528726155 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 52 payments from 11 companies in 2025. Trend: 2023 $1,114 · 2024 $1,848 · 2025 $1,003
Food & beverage: $997Education: $5
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $209 |
| Vanda Pharmaceuticals Inc. | 8 | $172 |
| Janssen Pharmaceuticals, Inc | 10 | $157 |
| E.R. Squibb & Sons, L.L.C. | 5 | $119 |
| Neurocrine BioSciences, Inc. | 4 | $108 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Alkermes, Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $18 |
Products named: UZEDY, FANAPT, COBENFY, INGREZZA, INVEGA SUSTENNA, REXULTI, AUSTEDO XR, SPRAVATO.
Industry payments across NY — which companies pay providers there.
